1 |
0.5 mg budesonide effervescent tablet for orodispersible use |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
2 |
1 mg budesonide effervescent tablet for orodispersible use |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
3 |
1mg budesonide effervescent tablet for orodispersible use |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
4 |
2mg budesonide effervescent tablet for orodispersible use |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
5 |
5 mg montelukast |
Montelukast |
[2] D00529 D00529, D08229 D08229 💬 |
CYSLTR1 [1] CYSLTR1 💬 |
Calcium signaling pathway [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
6 |
Ak002 |
- |
- |
- |
- |
098 [1] 98 💬 |
7 |
Allergen |
- |
- |
- |
- |
098 [1] 98 💬 |
8 |
Allergy immunotherapy (allergy shots) |
- |
- |
- |
- |
098 [1] 98 💬 |
9 |
Antolimab |
- |
- |
- |
- |
098 [1] 98 💬 |
10 |
Apt-1011 |
- |
- |
- |
- |
098 [1] 98 💬 |
11 |
Apt-1011 - 3 mg |
- |
- |
- |
- |
098 [1] 98 💬 |
12 |
Barium |
Barium |
- |
- |
- |
019 [2] 19, 98 💬 |
13 |
Beclomethasone dipropionate |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [2] 97, 98 💬 |
14 |
Behavioral: six-foods elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
15 |
Benralizumab |
Benralizumab |
[1] D09874 D09874 💬 |
IL5RA [1] IL5RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
044 [4] 44, 45, 98, 162 💬 |
16 |
Bethanechol |
Bethanechol |
[1] D01000 D01000 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
098 [1] 98 💬 |
17 |
Budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
18 |
Budesonide 0.5mg orodispersible tablet twice daily |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
19 |
Budesonide 1mg orodispersible tablet twice daily |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
20 |
Budesonide [0.4mg/ml] viscous suspension |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
21 |
Budesonide oral suspension |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
22 |
Budesonide oral suspension [0.2 mg/ml] |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
23 |
Budesonide plus prevacid |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
24 |
Buet 0.5 mg |
- |
- |
- |
- |
098 [1] 98 💬 |
25 |
Buet 1mg |
- |
- |
- |
- |
098 [1] 98 💬 |
26 |
Buet 2mg |
- |
- |
- |
- |
098 [1] 98 💬 |
27 |
Buu 0.4mg/ml |
- |
- |
- |
- |
098 [1] 98 💬 |
28 |
Caly-002 |
- |
- |
- |
- |
098 [1] 98 💬 |
29 |
Cromolyn |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
002 [3] 2 , 85, 98 💬 |
30 |
Device: esophacap |
- |
- |
- |
- |
098 [1] 98 💬 |
31 |
Device: intraluminal impedance |
- |
- |
- |
- |
098 [1] 98 💬 |
32 |
Device: niox mino® airway inflammation monitor |
Methamidophos |
- |
- |
- |
098 [1] 98 💬 |
33 |
Device: novel allergen-specific immune signature directed approach to dietary elimination therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
34 |
Dexlansoprazole |
Dexlansoprazole |
[1] D08903 D08903 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 [1] 98 💬 |
35 |
Diagnostic test: barium esophagram |
Barium |
- |
- |
- |
098 [1] 98 💬 |
36 |
Diagnostic test: bone mineral density (dexa) scan |
- |
- |
- |
- |
098 [1] 98 💬 |
37 |
Diagnostic test: endoscopy while on study drug |
- |
- |
- |
- |
098 [1] 98 💬 |
38 |
Diagnostic test: height measurement |
- |
- |
- |
- |
098 [1] 98 💬 |
39 |
Diagnostic test: physical examination and questionnaires |
- |
- |
- |
- |
098 [1] 98 💬 |
40 |
Diagnostic test: retrospective evaluation of endoscopy prior to study drug |
- |
- |
- |
- |
098 [1] 98 💬 |
41 |
Diagnostic test: vitamin d measurement |
Vitamin D |
- |
- |
- |
098 [1] 98 💬 |
42 |
Dupilumab |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 [4] 51, 98, 160, 162 💬 |
43 |
Dupilumab (blinded) |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
098 [1] 98 💬 |
44 |
Dupilumab (open-label) |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
098 [1] 98 💬 |
45 |
Dupixent |
- |
- |
- |
- |
098 [3] 98, 160, 162 💬 |
46 |
Eso-101 |
- |
- |
- |
- |
098 [1] 98 💬 |
47 |
Esomeprazole |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [6] 13, 46, 86, 98, 298, 299 💬 |
48 |
Eur-1100 |
- |
- |
- |
- |
098 [1] 98 💬 |
49 |
Famotidine |
Famotidine |
[1] D00318 D00318 💬 |
HRH2 [1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
006 [4] 6 , 46, 86, 98 💬 |
50 |
Florence 30 µg/ml |
- |
- |
- |
- |
098 [1] 98 💬 |
51 |
Florence 60 µg/ml |
- |
- |
- |
- |
098 [1] 98 💬 |
52 |
Florence 90 µg/ml |
- |
- |
- |
- |
098 [1] 98 💬 |
53 |
Flovent |
- |
- |
- |
- |
098 [1] 98 💬 |
54 |
Fluticasone |
Fluticasone |
[1] D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [3] 98, 228, 299 💬 |
55 |
Fluticasone mdi |
Fluticasone |
[1] D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
56 |
Fluticasone propionate |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [2] 98, 228 💬 |
57 |
Fluticasone propionate, 800 mcg twice daily (post 4fed failure) |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
58 |
Fluticasone propionate, 880 mcg twice daily (after 6fed failure) |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
59 |
Fluticasone propionate, usp |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
60 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
61 |
High dose budesonide suspension |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
62 |
High dose budesonide tablet |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
63 |
Honey |
Honey |
[1] D06776 D06776 💬 |
- |
- |
057 [3] 57, 98, 299 💬 |
64 |
Infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 [24] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
65 |
Inhaled/swallowed budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
66 |
Intubated with propofol (ip) |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
098 [1] 98 💬 |
67 |
Intubated with sevoflurane (is) |
Sevoflurane |
[1] D00547 D00547 💬 |
- |
- |
098 [1] 98 💬 |
68 |
Lansoprazole |
Lansoprazole |
[1] D00355 D00355 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [7] 63, 71, 85, 98, 166, 222, 299 💬 |
69 |
Lirentelimab |
- |
- |
- |
- |
098 [1] 98 💬 |
70 |
Lirentelimab (ak002) |
- |
- |
- |
- |
098 [1] 98 💬 |
71 |
Loratadine |
Loratadine |
[1] D00364 D00364 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [3] 13, 46, 98 💬 |
72 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
73 |
Losartan potassium |
Losartan |
[3] D00357 D00357, D08146 D08146, D08403 D08403 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 [5] 36, 98, 167, 179, 215 💬 |
74 |
Low dose budesonide tablet |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
75 |
Medi-563 |
- |
- |
- |
- |
044 [3] 44, 45, 98 💬 |
76 |
Mepolizumab |
Mepolizumab |
[1] D04923 D04923 💬 |
IL5 [1] IL5 💬 |
Allograft rejection [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
044 [4] 44, 45, 98, 162 💬 |
77 |
Mepolizumab 100 mg |
Mepolizumab |
[1] D04923 D04923 💬 |
IL5 [1] IL5 💬 |
Allograft rejection [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
098 [1] 98 💬 |
78 |
Mepolizumab 300 mg |
Mepolizumab |
[1] D04923 D04923 💬 |
IL5 [1] IL5 💬 |
Allograft rejection [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
098 [1] 98 💬 |
79 |
Milk |
Cow milk |
- |
- |
- |
098 [2] 98, 210 💬 |
80 |
Mometasone |
Mometasone |
[3] D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [2] 98, 162 💬 |
81 |
Mometasone furoate |
Mometasone |
[3] D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [2] 98, 162 💬 |
82 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
83 |
Montelukast |
Montelukast |
[2] D00529 D00529, D08229 D08229 💬 |
CYSLTR1 [1] CYSLTR1 💬 |
Calcium signaling pathway [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction |
013 [5] 13, 46, 85, 98, 228 💬 |
84 |
Montelukast/ singulair |
Montelukast |
[2] D00529 D00529, D08229 D08229 💬 |
CYSLTR1 [1] CYSLTR1 💬 |
Calcium signaling pathway [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
85 |
Nasonex |
- |
- |
- |
- |
098 [1] 98 💬 |
86 |
Nitric oxide |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
046 [8] 46, 85, 86, 98, 210, 251, 294, 299 💬 |
87 |
Oc000459 |
- |
- |
- |
- |
098 [1] 98 💬 |
88 |
Omalizumab |
Omalizumab |
[1] D05251 D05251 💬 |
FCER1A [1] FCER1A 💬 |
Asthma [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
046 [7] 46, 53, 65, 98, 162, 226, 299 💬 |
89 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
90 |
Omeprazole 20mg bid |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 [1] 98 💬 |
91 |
Oral budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
92 |
Oral budesonide suspension (mb-9) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
93 |
Oral budesonide suspension (obs) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
94 |
Oral cromolyn sodium |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
098 [1] 98 💬 |
95 |
Oral viscous budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
96 |
Oral viscous budesonide (ovb) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
97 |
Other: 1 food elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
98 |
Other: 1 food elimination diet therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
99 |
Other: 4 food elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
100 |
Other: 4 food elimination diet (post 1fed failure) |
- |
- |
- |
- |
098 [1] 98 💬 |
101 |
Other: 6 food elimination diet (after 1fed failure) |
- |
- |
- |
- |
098 [1] 98 💬 |
102 |
Other: 6 food elimination diet therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
103 |
Other: antigen (wheat base soy sauce) spray |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
098 [1] 98 💬 |
104 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 [1] 98 💬 |
105 |
Other: d-xylose |
Xylose |
[1] D06346 D06346 💬 |
- |
- |
098 [1] 98 💬 |
106 |
Other: elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
107 |
Other: honey |
Honey |
[1] D06776 D06776 💬 |
- |
- |
098 [1] 98 💬 |
108 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 [1] 98 💬 |
109 |
Other: oral nitric oxide testing |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
098 [1] 98 💬 |
110 |
Other: saline |
- |
- |
- |
- |
002 [8] 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
111 |
Other: symptom survey |
- |
- |
- |
- |
098 [1] 98 💬 |
112 |
Other: xanthan gum |
Xanthan gum |
[1] D06333 D06333 💬 |
- |
- |
098 [1] 98 💬 |
113 |
Potassium |
Potassium |
[1] D08403 D08403 💬 |
- |
- |
036 [10] 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
114 |
Procedure: esophageal dilation |
- |
- |
- |
- |
098 [1] 98 💬 |
115 |
Procedure: esophagogastroduodenoscopy |
- |
- |
- |
- |
098 [1] 98 💬 |
116 |
Procedure: intraluminal impedance |
- |
- |
- |
- |
098 [1] 98 💬 |
117 |
Propofol |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [8] 6 , 21, 22, 34, 46, 84, 98, 296 💬 |
118 |
Qax576 |
- |
- |
- |
- |
051 [4] 51, 85, 96, 98 💬 |
119 |
Radiation: computerized tomography scan |
- |
- |
- |
- |
098 [1] 98 💬 |
120 |
Radiation: esophageal barium xray |
Barium |
- |
- |
- |
098 [1] 98 💬 |
121 |
Radiation: planar images |
- |
- |
- |
- |
098 [1] 98 💬 |
122 |
Radiation: single photon emission computed tomography scans |
- |
- |
- |
- |
098 [1] 98 💬 |
123 |
Reslizumab |
Reslizumab |
[1] D08985 D08985 💬 |
IL5 [1] IL5 💬 |
Allograft rejection [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
044 [2] 44, 98 💬 |
124 |
Rpc4046 |
- |
- |
- |
- |
098 [1] 98 💬 |
125 |
Sb-240563 |
- |
- |
- |
- |
044 [3] 44, 45, 98 💬 |
126 |
Sch55700 |
- |
- |
- |
- |
098 [1] 98 💬 |
127 |
Sevoflurane |
Sevoflurane |
[1] D00547 D00547 💬 |
- |
- |
006 [6] 6 , 21, 22, 34, 98, 296 💬 |
128 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
129 |
Steroid and proton pump inhibitor therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
130 |
Sucralfate |
Sucralfate |
[1] D00446 D00446 💬 |
- |
- |
098 [1] 98 💬 |
131 |
Swallowed fluticasone |
Fluticasone |
[1] D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
132 |
Technetium tc 99m |
Technetium Tc-99m |
- |
- |
- |
046 [2] 46, 98 💬 |
133 |
Treat with lansoprazole 30 mg bid for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms |
Lansoprazole |
[1] D00355 D00355 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 [1] 98 💬 |
134 |
Viaskin milk 500 mcg |
Cow milk |
- |
- |
- |
098 [1] 98 💬 |
135 |
Viscous/swallowed budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
136 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 [21] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
137 |
Vonoprazan |
Vonoprazan |
[1] D11784 D11784 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [2] 63, 98 💬 |
138 |
Wheat |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
098 [2] 98, 266 💬 |
139 |
Xanthan gum |
Xanthan gum |
[1] D06333 D06333 💬 |
- |
- |
098 [1] 98 💬 |
140 |
Xylose |
Xylose |
[1] D06346 D06346 💬 |
- |
- |
098 [1] 98 💬 |
141 |
Zofran - no intubation |
- |
- |
- |
- |
098 [1] 98 💬 |